New drug duo targets Tough-to-Treat blood cancer
Disease control
Not yet recruiting
This study is testing whether a combination of two drugs, pacritinib and selinexor, can help control myelofibrosis in patients who have not yet tried a common type of treatment (JAK inhibitors) and who have low red blood cell and platelet counts. The main goals are to see if the …
Phase: PHASE2 • Sponsor: John Mascarenhas • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC